Trillium Therapeutics shares soar on Pfizer’s $2.26B deal on August 23, 2021 Get link Facebook X Pinterest Email Other Apps Trillium Therapeutics shares soar on Pfizer’s $2.26B deal Pfizer's $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies. Comments
Comments
Post a Comment